The Great Healthcare Plan has threatened the biopharma sector with mandatory global price parity, but the market is overlooking a critical carve-out specific to Pfizer. While competitors face ...
American pharma giant Pfizer (PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded medications, according to data seen by Reuters. The move underscores the ...
Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated a Buy rating on Pfizer Inc. (NYSE:PFE) on December 17 and set a price ...
Pfizer Inc. (NYSE: PFE) is scheduled to provide its full-year 2026 financial guidance on Tuesday, with Bank of America Securities expecting the company's growth profile to closely resemble conditions ...
Pfizer Inc. (NYSE:PFE) is one of the Cheap NYSE Stocks to Buy Now. On December 6, Pfizer Inc. (NYSE: PFE) announced results from its Phase 3 BASIS Study, which evaluates HYMPAVZI for people living ...
Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer (NYSE:PFE) revealed 20 unusual trades. Delving into the details, we found 35% of traders ...
Fintel reports that on December 2, 2025, Citigroup reiterated coverage of Pfizer (NYSE:PFE) with a Neutral recommendation. Analyst Price Forecast Suggests 16.49% Upside As of November 17, 2025, the ...
ARLETA, CA - AUGUST 02: Fernandeno Tataviam Band of Mission Indians, as part of its participation in the Medi-Vaxx Program of the San Fernando Valley, with El Proyecto del Barrio, Los Angeles Mission ...
Stock index futures fell on Monday, as investors assessed President Donald Trump's new H-1B visa fees. Here are four stocks to watch on the day: Coca-Cola Company (KO) stock was nearly flat in ...
CHONGQING, CHINA - JULY 29: In this photo illustration, a smartphone displays the logo of Moderna Inc. (NASDAQ: MRNA), a biotechnology company known for its mRNA-based vaccines and therapeutics, in ...
One of the most appealing features of Pfizer's stock is its dividend. The payout recently yielded a hefty 7.4% -- and it's been growing over time. There's reason to be bullish over Pfizer's long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results